When incubated with S. aureus-derived PGN, TLR2 induced CCL5, CCL17, and CCL22 production in LCs from AD patients [9, 10], suggesting that TLR2-mediated chemokine production may be a crucial process that protects against skin bacterial infection and contribute to the development of AD. This evidence concerns the gene CCL5 and Alzheimer disease.